Preclinical Research

  • Preclinical Research
  • Acute Dermal Irritation Response in White Sinclair and Hanford Miniature Swine

    PCR testing continues to be in the spotlight as a reliable way of screening for COVID-19 and other viruses in patients. Its amplification process enables it to detect small portions of genetic material in these viruses. But PCR can be also used for a broad range of additional applications.

    Case Study―Safety Assessment of Intravitreal Implants in Dutch Belted Rabbits

    Ophthalmic medications have a particular set of challenges that can impact their speedy and successful path to market. From prototype formulation through preclinical testing, early-phase clinical and manufacturing and development, ophthalmic drug development presents with specific and unique complexities. It is best to entrust drug development to a partner with regulatory knowledge, technical expertise, and a thorough understanding of the market in this growing therapeutic area. From current reality to future trends, being at the forefront of ophthalmic drug development delivers tangible benefits to sponsors.

    In Issue 27 of The Altascientist, we dive into all areas of ophthalmic drug development, including: 

    • Prototype development, formulation, and manufacturing
    • Preparing for first-in-human studies
    • Species and strain selection parameters
    • Routes of administration
    • Specialized ocular assessments and equipment
    • bioanalysis
    • Phase I clinical research
    • Phase II to commercialization

    Three case studies are also included!

     

     

    Comparing Cytokine Data to In-Life Parameters on Nonhuman Primates in Nonclinical Toxicology Studies

    .custom-column-left-text { float: left; width: 50%; padding-right: 10px; } .custom-column-right-text { float: right; width: 45%; text-align:center; } @media only screen and (max-width: 600px) { .custom-column-left-text, .custom-column-right-text, .custom-column-flc-ebook-text { float:none; width:80%; margin:0 auto; } }

    Drug development exists within the context of interrelated social factors that impact its norms and practices.

    One Integrated Solution for Meeting Your Preclinical to Clinical Drug Development Needs

    Establishment of Historical Control Reference Values of Cambodian Cynomolgus Macaque Blood Gases

    Evaluating Cytokine Data in Nonhuman Primate Safety Assessment Studies: A Correlation to Toxicity Outcomes

    .custom-column-left-text { float: left; width: 50%; padding-right: 10px; } .custom-column-right-text { float: right; width: 45%; text-align:center; } @media only screen and (max-width: 600px) { .custom-column-left-text, .custom-column-right-text, .custom-column-flc-ebook-text { float:none; width:80%; margin:0 auto; } }

    Meet Dr. Simone Iwabe, DVM, PhD, DACVO
    Senior Veterinary Ophthalmologist

    Subscribe to Preclinical Research